Our mission is to provide niche pharmaceuticals for patients with special needs or for specific situations in health care. We aim to satisfy unmet medical needs for patients and caregivers in Europe.
High quality services
We strive to offer high quality services for the benefit of both patients, customers, payers and partners to meet their needs and secure access to smaller specialty products for patients with rare disorders.
- Positive 2-year results with MD1003 in progressive MS
- GS-101 (aganirsen) in the Nordic countries
- Medical Need and Laboratoires CTRS in Nordic collaboration
- Medical Needs partner Atlantic Healthcare announces start of pivotal PhIII trial with alicaforsen in pouchitis
- Additional results for MD1003 (Cerenday)
Gene Signal and Medical Need enter into collaboration for GS-101 (aganirsen) in the Nordic countries